Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease
Hematological Oncology · 2023
DOI: 10.1002/hon.3135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2023. Verfasst von Foteini Theodorakakou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Amyloidosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Patients with cardiac light chain amyloidosis and Mayo stage 3b disease define a high‐risk population with very poor prognosis. Here, we report treatment outcomes of 80 consecutive patients with newly diagnosed AL and Mayo 3b who received novel regimens. Early mortality (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
- 2nd Department of Radiology, Research Unit of Radiology and Medical Imaging, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
ORCID-Profile: Foteini Theodorakakou
Zitieren
APA
Theodorakakou, F., Briasoulis, A., Fotiou, D., Petropoulos, I., Georgiopoulos, G., Lama, N., Kelekis, N., Repasos, E., Migkou, M., Stamatelopoulos, K., Dimopoulos, M. A., & Kastritis, E. (2023). Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease. Hematological Oncology. https://doi.org/10.1002/hon.3135
Vancouver
Theodorakakou F, Briasoulis A, Fotiou D, Petropoulos I, Georgiopoulos G, Lama N, et al. Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease. Hematological Oncology. 2023. doi:10.1002/hon.3135
BibTeX
@article{Theodorakakou2023,
author = {Theodorakakou, Foteini and Briasoulis, Alexandros and Fotiou, Despina and Petropoulos, Ioannis and Georgiopoulos, Georgios and Lama, Niki and Kelekis, Nikolaos and Repasos, Evangelos and Migkou, Magdalini and Stamatelopoulos, Kimon and Dimopoulos, Meletios A and Kastritis, Efstathios},
title = {Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease},
journal = {Hematological Oncology},
year = {2023},
doi = {10.1002/hon.3135}
}
EUVIMED